Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Damages
11
Nov 05, 2015 11:24AM
7
Nov 05, 2015 11:57AM
5
Nov 05, 2015 01:02PM
6
Nov 05, 2015 01:59PM
5
Nov 05, 2015 03:17PM

At this point, I'd accept no less than $0.50/share in damages.

Add to that going forward with dividends from new licenses and growth in share price.

Lingering questions going forward: So the lists are split, do we still share the revenues no matter who bags a license? Does PDS still approve each and every license?

2
Nov 06, 2015 09:16AM
3
Nov 06, 2015 09:32AM
3
Nov 06, 2015 10:15AM
7
Nov 06, 2015 10:43AM
4
Nov 06, 2015 04:22PM
3
Nov 06, 2015 07:22PM
1
Nov 06, 2015 08:38PM
4
Nov 07, 2015 04:37PM
4
Nov 07, 2015 09:20PM
Share
New Message
Please login to post a reply